Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition - Twists and Turns: Pancreas, Cholangio, and Bowel MRI

Twists and Turns: Pancreas, Cholangio, and Bowel MRI

Digital Poster

Body

Thursday, 14 May 2026

Digital Posters Row J

14:35 - 15:30

Session Number: 669-04

No CME/CE Credit

Similar Sessions

This session includes presentations that utilize MRI in pancreas, cholangio, and bowel MRI.

Skill Level: Intermediate

		669-04-001. Intravenous glucose stimulated pancreas BOLD MRI: preliminary findings in normoglycemic individuals with cystic fibrosis David Reiter, Anna Horner, Priyathama Vellanki, Lisa Staimez Emory University, Atlanta, United States of America Impact: Preliminary findings show differences in pancreas BOLD MRI response after intravenous glucose stimulation between individuals with and without cystic fibrosis, consistent with differences in beta-cell functional response. These findings show translational potential for assessing pancreas metabolic abnormalities that precede diabetes.
		669-04-002. Multiparametric MRI to assess the Effects of Oxygenated Hypothermic Machine Perfusion on Ex-Vivo Pancreases Alexander Daniel, Mohamed Elzawahry, Aaron Axford, Damian Tyler, Susan Francis, James Hunter University of Nottingham, Nottingham, United Kingdom Impact: This work demonstrates the feasibility of ex-vivo quantitative MRI to study the pancreas and assess the effects of preservation techniques. In future, a proven method for non-invasive assessment of the pancreas prior to transplant could improve transplant rates.
		669-04-003. Clinical evaluation of deep learning accelerated 3D magnetic resonance cholangiopancreatography at 1.5T and 3T Ivan Jambor, Ranjodh Dhami, Madhangi Parameswaran, Eugene Milshteyn, Ajeetkumar Gaddipati, MARY THOMAS, Arnaud Guidon, Azadeh Tabari, Susie Huang, Clare Tempany, Mukesh Harisinghani, Rory Cochran Enterprise Service Group – Radiology at Mass General Brigham, United States of America Impact: Deep learning accelerated, Deep Learning Speed (DLS), MRCP (breath-hold 11-17s) has better image quality consistency with shorter scan time compared to standard MRCP performed either as resolution breath‐hold (BH) acquisition or higher resolution triggered navigator breathing (NAV) acquisition.
		669-04-004. MR Elastography in the pancreas and pancreatic ductal adenocarcinoma Anne-Sophie van Schelt, Marina Cimprich, Thomas Vogl, Ralph Sinkus, Vitali Koch King's College London, London, United Kingdom Impact: This work demonstrates that MRE-derived stiffness quantification discriminates PDAC from other pancreatic lesions and associates with treatment response. These promising results underscore the need for further MRE validation with quantifying stromal deposition to establish stiffness as a predictor for response.
		669-04-005. Deep learning-based pancreatic age estimation from MRI predicts incident diabetes beyond known risk factors Matthias Jung, Robin Schirrmeister, Marco Reisert, Zeynep Berkarda, Susanne Rospleszcz, Christopher Schlett, Fabian Bamberg, Vineet Raghu, Jakob Weiß University Medical Center Freiburg — Department of Diagnostic and Interventional Radiology, Freiburg, Germany Impact: Organ-specific biological age estimation of the pancreas from MRI-derived segmentation masks (MRI-PancAge) predicts future type 2 diabetes beyond chronological age and known risk factors. Individuals at high MRI-PancAge could benefit from personalized prevention strategies, lifestyle interventions, and treatment planning.
		669-04-006. Assessing Fibrotic Multimorbidity using Multiorgan MRI data in the UK Biobank Margot Roeth, Eleanor Cox, Martin Craig, Ali-Reza Mohammadi-Nejad, Ruizhe Li, Zhendi Gong, Gisli Jenkins, Stam Sotiropoulos, Dorothee Auer, Xin Chen, Susan Francis NIHR Nottingham Biomedical Research Centre, Queen’s Medical Centre, Nottingham, United Kingdom Impact: Fibrotic diseases cause multiorgan changes which are measurable using quantitative MRI. Population level MRI changes in the UK Biobank allowed MRI patterns associated with fibrotic disease to be identified and an MRI-based Fibrotic MultiMorbidity Score generated to assess mortality risk.
		669-04-007. Small-bowel motility is lower in humans with obesity vs. healthy weight and this is altered by weight loss – an MRI study Catharina de Jonge, Katy van Galen, Femke Struik, Susanne la Fleur, Mireille Serlie Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands Impact: This study identifies small-bowel motility differences in obesity vs. healthy bodyweight and alterations in obese individuals after weight loss, offering a non-invasive method for gut-brain-axis research to understand the mechanisms underlying motility changes and guide researchers to new therapies.
		669-04-008. Multiparametric MRI Assessment of Crohn’s Disease Activity: Comparative Diagnostic Performance of ADC, K, and RCE Xiaoyu Tong, Cai Lei, Huilou Liang, Jiayu Sun West China Hospital of Sichuan University, Chendu, China Impact: Ultrafast dynamic enhancement slope (K) provides superior diagnostic accuracy for Crohn’s disease activity compared with ADC and RCE. Integrating multiparametric MRI enhances noninvasive disease monitoring, potentially reducing reliance on invasive endoscopy in clinical management.
		669-04-009. Dual-modality imaging strategy of preoperative MRI and intraoperative NIRF targeting perineural invasion of pancreatic cancer Juncheng Wu, Hebing Chen, Wenyi Deng, Zhilin Yuan, Xiang Li, Xingru Tan, Xinyu Zhang Peking Union Medical College Hospital, Beijing, China Impact: This novel GAP-43-targeting probe enables precise preoperative MRI and intraoperative navigation of perineural invasion, aiding surgeons in achieving complete tumor resection and improving patient survival in pancreatic cancer.
		669-04-010. Pancreatic T1, T2, T2* and PDFF in Healthy Indian Adult Population at 3.0T Monica Gunasingh, Nikhil Suryadevara, Jithin Sreekumar, Tharani Putta, Sashidhar Kaza, Rolla Narayana Krishna, Jaladhar Neelavalli Indian Institute of Technology, Hyderabad, India Impact: We establish the subregion-wise (head, body, tail) normal ranges of the pancreatic MR relaxation properties and proton density fat fraction in Indian healthy adult population. These nomograms can serve as reference values for planning future studies evaluating pancreatic diseases.
		669-04-011. Bowel Wall Relaxation in the Human Gut: Preliminary Findings at 3.0T Samuel Perron, Praveen Dassanayake, Heather Biernaski, Frank Prato, Gerald Moran, Neil Gelman Western University, London, Canada Impact: We present $T_1$ relaxation maps of the bowel walls at 3T and as-of-yet unreported mean $T_1$ values in healthy male volunteers. This preliminary data may inform pulse sequence and protocol design for abdominal imaging for digestive diseases.
		669-04-012. User-independent AI-based MRI analysis of hepatobiliary function in patients with primary sclerosing cholangitis Sina Dornbusch, Rebekka Fehling, Andrea Schenk, Eike Petersen, Felix Thielke, Alena Levers, Henrike Lenzen, Frank Wacker, Kristina Ringe Hannover Medical School, Hannover, Germany Impact: Our AI-based workflow transforms hepatobiliary phase-based biomarkers into practical clinical tools that enable regionally differentiated liver function assessment in a rapid and objective manner - potentially facilitating personalized monitoring in chronic liver diseases such as primary sclerosing cholangitis.
		669-04-013. Thin-Slice Oblique Coronal Zoomed DWI on Ultra-High Gradient System: Improved Evaluation of Extrahepatic Cholangiocarcinoma Lingsong Zhou, Beixuan Zheng, Xianling Qian, Xuhao Song, Jili Chen, Caixia Fu, Mengsu Zeng, Ruofan Sheng Zhongshan Hospital, Fudan University, Shanghai, China Impact: Thin-slice Oblique Coronal Zoomed DWI on an ultra-high gradient system demonstrates improved image quality, enhanced lesion delineation and more accurate tumor sizing for eCCA evaluation， showing strong potential for precise preoperative assessment and surgical guidance.
		669-04-014. Interrogating preventative treatment efficacy in premalignant pancreatic cysts by hyperpolarized magnetic resonance José Enriquez, Julia Zickus, Rian Howell, Olivereen Le Roux, Shivanand Pudakalakatti, Prasanta Dutta, Florencia McAllister, Pratip Bhattacharya The University of Texas MD Anderson Cancer Center, Houston, United States of America Impact: The ability to detect precancerous pancreatic lesions and prevent pancreatic cancer would revolutionize patient care and pancreatic cancer outcomes. HP-MR can detect these lesions and evaluate the efficacy of a KRAS inhibitor to reverse the onset of pancreatic cancer.
		669-04-015. The Value of focused MRI Protocols in Assessing Cystic Pancreatic Lesions Daniel Düx, Martina Schmidbauer, Alena Levers, Frank Wacker, Kristina Ringe Hannover Medical School, Hannover, Germany Impact: Adopting focused MRI (fMRI) protocols for cystic pancreatic lesion assessment can enhance patient care by offering diagnostic accuracy similar to comprehensive MRI while optimizing exam times, patient comfort and resources.